ResearcherCharles UniversityActive in the last 2 years
Michal Vočka
Matched on ORCID iD 0000-0002-9386-657X; OpenAlex author ID A5076719276. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers
Papers 9
- The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRC… Co-author DOI 10.48095/ccko2024292↗
- Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. Co-author DOI 10.5507/bp.2023.049↗
- Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Co-author DOI 10.1038/s41591-023-02640-w↗
- Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. First author DOI 10.4149/neo_2023_230409n193↗
- Novel biochemical markers for non-invasive detection of pancreatic cancer. Co-author DOI 10.4149/neo_2022_210730n1075↗
- Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers13174430↗
- [The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience]. Co-author DOI 10.14735/amko2017452↗
- Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Co-author DOI 10.1016/j.cancergen.2016.03.003↗
- The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. Co-author DOI 10.1016/j.gene.2016.04.056↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lubos B. Petruzelka · 4 shared papers, 2017–2024 · strength 0.67
- Paper Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. DOI 10.5507/bp.2023.049↗
- Paper Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.4149/neo_2023_230409n193↗
- Paper Novel biochemical markers for non-invasive detection of pancreatic cancer. DOI 10.4149/neo_2022_210730n1075↗
- Marta Kalousová · 3 shared papers, 2021–2024 · strength 0.45
- Paper Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. DOI 10.5507/bp.2023.049↗
- Paper Novel biochemical markers for non-invasive detection of pancreatic cancer. DOI 10.4149/neo_2022_210730n1075↗
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Tomáš Zima · 2 shared papers, 2022–2024 · strength 0.35
- Aleš Žák · 2 shared papers, 2022–2024 · strength 0.35
- P Hrabák · 2 shared papers, 2022–2024 · strength 0.35
- T Krechler · 2 shared papers, 2022–2024 · strength 0.35
- Petra Kleiblová · 4 shared papers, 2016–2024 · strength 0.35
- Paper The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pa… DOI 10.48095/ccko2024292↗
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Zdeněk Kleibl · 4 shared papers, 2016–2024 · strength 0.35
- Paper The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pa… DOI 10.48095/ccko2024292↗
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Markéta Janatová · 4 shared papers, 2016–2024 · strength 0.35
- Paper The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pa… DOI 10.48095/ccko2024292↗
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Marianna Borecká · 3 shared papers, 2016–2021 · strength 0.21
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Paper The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. DOI 10.1016/j.gene.2016.04.056↗
- Pavel Záruba · 1 shared paper, 2023 · strength 0.17
- Z Krška · 1 shared paper, 2023 · strength 0.17
- Jan Ulrych · 1 shared paper, 2023 · strength 0.17
- Soňa Argalácsová · 1 shared paper, 2023 · strength 0.17
- Miroslav Ryska · 1 shared paper, 2023 · strength 0.17
- David Hoskovec · 1 shared paper, 2023 · strength 0.17
- Alan Yuille · 1 shared paper, 2023 · strength 0.12
- Jiawen Yao · 1 shared paper, 2023 · strength 0.12
- Ling Zhang · 1 shared paper, 2023 · strength 0.12
- Xu Han · 1 shared paper, 2023 · strength 0.12
- Jianping Lu · 1 shared paper, 2023 · strength 0.12
- Qi Zhang · 1 shared paper, 2023 · strength 0.12
- Kai Cao · 1 shared paper, 2023 · strength 0.12
- Rong Zhang · 1 shared paper, 2023 · strength 0.12
- Yu Shi · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.